Table 3.
Anesthesia and pain management
| Study | No | Anesthesia | Pain management | |||||
|---|---|---|---|---|---|---|---|---|
| Antibiotic duration | Avoid long acting sedative | Optimized fluid management | Prevention of PONV | Epidural | Regional Infiltration | Non-epidural pain medication | ||
| Altobelli et al. [36] | 207 | 24 h | + | + | n.s | + | - | n.s |
| Baack Kukreja et al. [1] | 79 | 24 h | n.s | + | n.s | + (open) | + (lap) | NSAI + paracetamol ± weak opioids ± narcotics |
| Brockman et al. [25] | 152 | SD | n.s | + | n.s | + | − | n.s |
| Casans-Francés et al. [2] | 41 | SD | + | + (Protocol by Feldheiser et al. [39]) | + (Apfel scale) | + | – | NSAI |
| Cerruto et al. [26] | 9 | SD | + | + | + | + | + | NSAI |
| Collins et al. [5] | 135 | SD | + (spinal) | + | n.s | − | − | NSAI + opioid |
| Djaladat et al. [9], Djaladat et al. [9, 27] | 196 | stent removal | + | + | n.s | − | − | NSAI + Paracetamol |
| Dutton et al. [22] | 165 | SD | n.s | + | n.s | − | + (RSC) | NSAI + weak opioid |
| Frees et al. [3] | 12 | n.s | n.s | + (Doppler monitoring) | n.s | + | − | NSAI ± opioid |
| Jensen et al. [23] | 57 | SD | n.s | n.s | n.s | − | − | NSAI ± opioid |
| Koupparis et al. [37]- | 102 | n.s | n.s | + | + | + | − | Paracetamol + opioid |
| Lin et al. [7] | 144 | SD | n.s | n.s | n.s | − | − | n.s |
| Liu et al. [28] | 84 | SD | + | + | + | + | − | n.s |
| Maffezzini et al. [29] | 71 | drain removal | n.s | + | n.s | + | − | n.s |
| Mukhtar et al. [11] | 51 | n.s | + | + | + | + | − | non-opioid |
| Palumbo et al. [6] | 74 | POD 4 | + | + (Ringer’s acetate solution 1–2 mg/kg/h) | n.s | − | − | Paracetamol + diclofenac ± weak opioid |
| Pang et al. [31] | 393 | 24 h (m) 48 h (f) | + | + (< 1L before bladder removal, use of vasopressors) | + | − | + (RSC) | Paracetamol |
| Patel et al. [24] | 116 | n.s | n.s | + (minimally invasive volume monitor) | n.s | + | − | Paracetamol |
| Persson et al. [32] | 31 | SD | + | + | + | + | − | n.s |
| Rivas et al. [38] | 19 | SD | + | + | n.s | + | − | Avoid opioid |
| Saar et al. [8] | 31 | SD | - | - | − | − | − | diclofenac + NSAI ± opioids |
| Semerjian et al. [33] | 56 | 24 h | + | + (125-200 ml Ringer/h ± bolus depending on losses, phenylephrine) | + | + (open) | + (Robotic: TAP-Block) | Paracetamol + gabapentin + tranSDermal lidocaine ± weak opioid ± opioid |
| Smith et al. [34] | 27 | n.s | n.s | + (esophageal doppler) | n.s | − | + (RSC) | n.s |
| Tan et al. [10] | 40 | n.s | + (spinal) | + (esophageal doppler) | n.s | − | − | NSAI + Paracetamol ± opioid |
| Wei et al. [35] | 91 | n.s | n.s | + (vascular pressure) | n.s | + | + (RSC) | intravenous opioid on demand |
+ used, − not used, n.s. not specified, SD single dose, RSC rectus sheath catheter, TAP transversus abdominis plane block